Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Kashiwagi, H.
  • McDunn, Jonathan
  • Simon, P. O.
  • Goedegebuure, P. S.
  • Vangveravong, S.
  • Chang, K.
  • Hotchkiss, R. S.
  • Mach, R. H.
  • Hawkins, W. G.

publication date

  • March 2009

journal

  • Journal of Translational Medicine  Journal

subject areas

  • Adenocarcinoma
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols
  • Apoptosis
  • Cell Line, Tumor
  • Deoxycytidine
  • Disease Models, Animal
  • Female
  • Humans
  • Interphase
  • Ligands
  • Mice
  • Mice, Inbred C57BL
  • Paclitaxel
  • Pancreatic Neoplasms
  • Receptors, sigma
  • Survival Analysis
scroll to property group menus

Identity

PubMed Central ID

  • PMC2669042

International Standard Serial Number (ISSN)

  • 1479-5876

Digital Object Identifier (DOI)

  • 10.1186/1479-5876-7-24

PubMed ID

  • 19323815
scroll to property group menus

Additional Document Info

volume

  • 7

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support